ArticleAmerican journal of cancer research2015

TP53 modulating agent, CP-31398 enhances antitumor effects of ODC inhibitor in mouse model of urinary bladder transitional cell carcinoma.

Venkateshwar Madka et al.PubMed ↗Full text ↗

No numbers read from the abstract.